We recently identified the miR-17∼92 cluster as an important mediator of MYCN signaling in neuroblastoma with several components of this cluster down regulating expression of target genes such as DKK3 and members of the TGFβ pathway that contribute to the MYCN driven tumor phenotype [12]. The gene discussed is MYCN; the disease is neoplasm.